Header Logo

Connection

SEAN HARTIG to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications SEAN HARTIG has written about Xenograft Model Antitumor Assays.
SEAN HARTIG
Connection Strength
0.020
Xenograft Model Antitumor Assays
  1. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest. 2018 04 02; 128(4):1283-1299.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.